Log in

OTCMKTS:CVATCavitation Technologies Stock Price, Forecast & News

$0.01
0.00 (0.00 %)
(As of 05/25/2020 08:56 AM ET)
Add
Compare
Today's Range
$0.01
Now: $0.01
$0.01
50-Day Range
$0.01
MA: $0.01
$0.02
52-Week Range
$0.01
Now: $0.01
$0.04
Volume76,896 shs
Average Volume232,001 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Cavitation Technologies, Inc. develops, patents, and commercializes proprietary technology for use in liquid processing applications in the United States. It offers Nano Neutralization system for refining vegetable oils, such as soybean, rapeseed, canola, and palm oil. The company also designs technology based systems that are designed to serve various markets, such as vegetable oil refining, renewable fuels, water treatment, wines and spirits enhancement, algae oil extraction, water-oil emulsions, and crude oil yield enhancement. Cavitation Technologies, Inc. was founded in 2007 and is headquartered in Chatsworth, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.52 out of 5 stars


Industry, Sector and Symbol

Industry Agricultural Chemicals
Sub-IndustryN/A
SectorBasic Materials
Current SymbolOTCMKTS:CVAT
CUSIPN/A
CIKN/A
Phone+1-818-7180905

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees5
Next Earnings DateN/A
OptionableNot Optionable

Receive CVAT News and Ratings via Email

Sign-up to receive the latest news and ratings for CVAT and its competitors with MarketBeat's FREE daily newsletter.

Cavitation Technologies (OTCMKTS:CVAT) Frequently Asked Questions

How has Cavitation Technologies' stock been impacted by COVID-19 (Coronavirus)?

Cavitation Technologies' stock was trading at $0.0227 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CVAT stock has decreased by 38.3% and is now trading at $0.0140. View which stocks have been most impacted by Coronavirus.

Has Cavitation Technologies been receiving favorable news coverage?

News articles about CVAT stock have been trending somewhat positive recently, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Cavitation Technologies earned a media sentiment score of 1.5 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news aboutCavitation Technologies.

Who are some of Cavitation Technologies' key competitors?

What other stocks do shareholders of Cavitation Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cavitation Technologies investors own include Co-Diagnostics (CODX), Ibio (IBIO), Pharmacyte Biotech (PMCB), SANUWAVE Health (SNWV), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP), Ascent Solar Technologies (ASTI), BioRestorative Therapies (BRTX), Digital Ally (DGLY) and FuelCell Energy (FCEL).

Who are Cavitation Technologies' key executives?

Cavitation Technologies' management team includes the following people:
  • Mr. Igor Gorodnitsky, Co-Founder, Principal Exec. Officer, Pres & Director (Age 59)
  • Mr. Naum D. Voloshin, CFO & COO (Age 55)
  • Mr. Roman Gordon, Co-Founder & Global Technology Mang. (Age 69)
  • Mr. Maxim Promtov, Head of Research and Director of R&D

What is Cavitation Technologies' stock symbol?

Cavitation Technologies trades on the OTCMKTS under the ticker symbol "CVAT."

How do I buy shares of Cavitation Technologies?

Shares of CVAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Cavitation Technologies' stock price today?

One share of CVAT stock can currently be purchased for approximately $0.01.

What is Cavitation Technologies' official website?

The official website for Cavitation Technologies is www.ctinanotech.com.

How can I contact Cavitation Technologies?

Cavitation Technologies' mailing address is 10019 Canoga Ave, CHATSWORTH, CA 91311-3004, United States. The company can be reached via phone at +1-818-7180905.

This page was last updated on 5/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.